Loading comparison data...
Compare DENOSUMAB (CONEXXENCE) and RALOXIFENE (Raloxifene Hydrochloride) — clinical data, side effects, and patient experiences.
CONEXXENCE, Prolia, Xgeva · RANKL Inhibitor
How it works
12.1 Mechanism of Action Denosumab products bind to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of osteoclasts, the cells responsi...
Approved for
Raloxifene Hydrochloride, Evista · SERM
How it works
12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 7 Reddit discussions
DENOSUMAB
14%
positive
7 threads
RALOXIFENE
0%
positive
0 threads
% of discussions mentioning each side effect
7 Reddit threads analysed for DENOSUMAB
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
3 upvotes
Most discussed side effects in community
(Caucasian Female, 28,168 cm, 58kg, no other conditions) I have recently been diagnosed with a Giant Cell Tumor that essentially took out my T2. To avoid permanent damage to the spinal cord, doctors are planning to operate next week, taking out the tumor and fusing C7 through T3. Are there any alter
* Age - 79 * Sex - female * Height - 4'8" * Weight - 65kg * Race - white * Duration of complaint - 10 years + * Location (Geographic and on body) - spine * Any existing relevant medical issues (if any) - osteoporosis * Current medications (if any) - codeine, Prolia (denosumab), Adcal (vit d and calc
Hello, any advise/input would be helpful and greatly appreciated! I received worrisome labs on Friday. I am a 62-year-old Caucasian female, 5'2", 104lbs, with a history of osteoporosis, diverticulitis (resection done 6 years ago), and anxiety. Current medications include Zoloft 25 mg daily, and I a
The patient in question is a 23 year old white male. 5'8, 200lbs. Patient began having trouble with his left leg in November of 2015. He was diagnosed with a Giant Cell Tumor of the Bone in his tibia. He underwent surgery to remove it. By May of 2016, the tumor had recurred and the patient had anoth
* Age - 79 * Sex - female * Height - 4'8" * Weight - 65kg * Race - white * Duration of complaint - one week, she's mentioned low temp and I didn't pick up on it a few days back * Location (Geographic and on body) - spine * Any existing relevant medical issues (if any) - osteoporosis * Current medi
Hi! Can someone tell me if I should be worried about my mom labs? Today I found out she has Chromogranin A at 104 ng/ml (lab says normal is less than 100) She has no symptoms at all! Information: 54 years old Female She has osteoarthritis, osteoporosis and hyperlipidemia (controlled), for what s
Age 36 Male 260 lbs Never a smoker Barely drink So, long story short - back in Oct 2019 I had a punch biopsy into my sacrum for suspected cancer, but it came back inconclusive, so it was repeated and was then confirmed to be a Giant Cell Tumor. I recently had an operation to remove the tumor via
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for RALOXIFENE yet.
DENOSUMAB is a RANKL Inhibitor, while RALOXIFENE belongs to the SERM class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. DENOSUMAB is administered via Subcutaneous, whereas RALOXIFENE uses Oral. Route of administration can affect onset of action and patient adherence.
DENOSUMAB carries 4 FDA warnings. RALOXIFENE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.